<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral <z:hpo ids='HP_0000127'>salt wasting</z:hpo> (CSW) frequently occurs concomitantly with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>CSW induces excessive <z:mp ids='MP_0006316'>natriuresis</z:mp> and osmotic <z:mp ids='MP_0001762'>diuresis</z:mp>, reduces total blood volume, aggravates <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and causes <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> after SAH </plain></SENT>
<SENT sid="2" pm="."><plain>This study examined the inhibitory effect of <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> on CSW in rat SAH models </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="2" ids="17650">Hydrocortisone</z:chebi> had an inhibitory effect on CSW because <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> functioned in a dose-dependent manner to inhibit the increase in <z:chebi fb="199" ids="26708">sodium</z:chebi> excretion and <z:chebi fb="199" ids="26708">sodium</z:chebi>/<z:chebi fb="120" ids="26216">potassium</z:chebi> ratio after SAH <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi> is a useful drug for the treatment of CSW after SAH </plain></SENT>
</text></document>